Summary
Danaher Corporation (DHR) filed an 8-K on July 20, 2006, to report its financial results for the second quarter and first six months ended June 30, 2006. The press release, furnished as Exhibit 99.1, announced record results, indicating strong operational performance during the period. This filing is crucial for investors as it provides updated financial data and performance metrics for the company. The "record" results suggest positive trends in revenue, profitability, or other key financial indicators, which could influence investment decisions. Investors should refer to the press release for specific details on the financial performance and any forward-looking statements or management commentary.
Key Highlights
- 1Danaher Corporation filed an 8-K on July 20, 2006, reporting Q2 and H1 2006 results.
- 2The filing includes a press release announcing "record" second quarter results.
- 3The press release (Exhibit 99.1) is the primary source of the financial information disclosed.
- 4The report is furnished under Item 2.02 of Form 8-K, related to Results of Operations and Financial Condition.
- 5This filing provides investors with updated financial performance data for Danaher.
- 6The information provided is not deemed 'filed' for Section 18 purposes but is incorporated by reference into future filings if expressly stated.
Frequently Asked Questions
The main purpose of this 8-K filing is to announce and provide DHR's financial results for the second quarter and the first six months ended June 30, 2006, as detailed in an accompanying press release.
The press release, titled 'Danaher Announces Record Second Quarter Results,' indicates that the company achieved its best-ever performance for the second quarter, suggesting strong revenue and/or profit growth.
The detailed financial information is primarily contained within the press release titled 'Danaher Announces Record Second Quarter Results,' which is furnished as Exhibit 99.1 to this 8-K filing.
No, the information furnished in this press release is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. However, it can be incorporated by reference into future SEC filings if explicitly stated in those filings.